Difference between revisions of "Amyloid beta A4 peptide"
m |
m |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:Beta_amyloid.JPG|200px|{{PAGENAME}}]] | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Beta_amyloid.JPG|200px|{{PAGENAME}}]] | ||
Line 52: | Line 52: | ||
| | | | ||
|- | |- | ||
− | | {{infobox header | + | | Video |
+ | |{{#ev:dailymotion|7qzKHArw798dckRrh|300}} | ||
+ | |- | ||
+ | | {infobox header} | | ||
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 11:23, 10 March 2015
Amyloid beta A4 peptide | |
---|---|
Substrate peptide name | Amyloid beta A4 peptide |
Synonyms | Alzheimer disease amyloid protein |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular; cerebrospinal fluid
Alzheimer's disease neuritic plaques |
Swissprot ID | P05067 |
Reactive glutamines | Q15 |
Reactive lysines | K16, K28 |
Substrate sequence | YEVHHQKLVFFA
DVGSNKGAIIG |
Structure | 1AML |
Surface accessibility | ASAView pdf
ASAView txt |
Disorder prediction | IUPred |
Reference | PMID:7905838 |
Notes | |
Video | 7qzKHArw798dckRrh|300}} |